全文获取类型
收费全文 | 13157篇 |
免费 | 1130篇 |
国内免费 | 7篇 |
出版年
2022年 | 85篇 |
2021年 | 169篇 |
2020年 | 89篇 |
2019年 | 148篇 |
2018年 | 133篇 |
2017年 | 119篇 |
2016年 | 264篇 |
2015年 | 456篇 |
2014年 | 504篇 |
2013年 | 695篇 |
2012年 | 826篇 |
2011年 | 844篇 |
2010年 | 533篇 |
2009年 | 510篇 |
2008年 | 728篇 |
2007年 | 735篇 |
2006年 | 643篇 |
2005年 | 705篇 |
2004年 | 679篇 |
2003年 | 615篇 |
2002年 | 609篇 |
2001年 | 118篇 |
2000年 | 99篇 |
1999年 | 123篇 |
1998年 | 171篇 |
1997年 | 112篇 |
1996年 | 104篇 |
1995年 | 91篇 |
1994年 | 92篇 |
1993年 | 88篇 |
1992年 | 98篇 |
1991年 | 86篇 |
1990年 | 82篇 |
1989年 | 71篇 |
1988年 | 76篇 |
1987年 | 85篇 |
1986年 | 86篇 |
1985年 | 82篇 |
1984年 | 125篇 |
1983年 | 100篇 |
1982年 | 125篇 |
1981年 | 130篇 |
1980年 | 145篇 |
1979年 | 111篇 |
1978年 | 103篇 |
1977年 | 108篇 |
1976年 | 85篇 |
1975年 | 84篇 |
1974年 | 93篇 |
1973年 | 74篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
2.
3.
4.
Epithelial ovarian carcinoma (EOC), the major cause of gynaecological cancer death, is a heterogeneous disease classified into five subtypes. Each subtype has distinct clinical characteristics and is associated with different genetic risk factors and molecular events, but all are treated with surgery and platinum/taxane regimes. Tumour progression and chemoresistance is generally associated with major metabolic alterations, notably altered mitochondrial function(s). Here, we report for the first time that the expression of the mitochondrial regulators PGC1α and TFAM varies between EOC subtypes; furthermore, we have identified a profile in clear-cell carcinoma consisting of undetectability of PGC1α/TFAM, and low ERα/Ki-67. By contrast, high-grade serous carcinomas were characterised by a converse state of PGC1α/TFAM, ERα positivity and a high Ki-67 index. Interestingly, loss of PGC1α/TFAM and ERα was found also in a non-clear cell EOC cell line made highly resistant to platinum in vitro. Similar to clear-cell carcinomas, these resistant cells also showed accumulation of glycogen. Altogether, our data provide mechanistic insights into the chemoresistant nature of ovarian clear-cell carcinomas. Furthermore, these findings corroborate the need to take into account the diversity of EOC and to develop subtype specific treatment strategies. 相似文献
5.
Edward Harrison 《BMJ (Clinical research ed.)》1916,1(2888):645-647
6.
Transcriptional regulatory network triggered by oxidative signals configures the early response mechanisms of japonica rice to chilling stress 总被引:3,自引:0,他引:3
7.
8.
9.
Ralf Heinrich Peter Bräunig Ismeni Walter Henning Schneider Edward A. Kravitz 《Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology》2000,186(7-8):617-629
In the American lobster (Homarus americanus) the biogenic amines serotonin and octopamine appear to play important and opposite roles in the regulation of aggressive behavior, in the establishment and/or maintenance of dominant and subordinate behavioral states and in the modulation of the associated postural stances and escape responses. The octopamine-containing neurosecretory neurons in the thoracic regions of the lobster ventral nerve cord fall into two morphological subgroups, the root octopamine cells, a classical neurohemal group with release regions along second thoracic roots, and the claw octopamine cells, a group that selectively innervates the claws. Cells of both subgroups have additional sets of endings within neuropil regions of ganglia of the ventral nerve cord. Octopamine neurosecretory neurons generally are silent, but when spontaneously active or when activated, they show large overshooting action potentials with prominent after-hyperpolarizations. Autoinhibition after high-frequency firing, which is also seen in other crustacean neurosecretory cells, is readily apparent in these cells. The cells show no spontaneous synaptic activity, but appear to be excited by a unitary source. Stimulation of lateral or medial giant axons, which excite serotonergic cells yielded no response in octopaminergic neurosecretory cells and no evidence for direct interactions between pairs of octopamine neurons, or between the octopaminergic and the serotonergic sets of neurosecretory neurons was found. 相似文献
10.